Drug Trial Radar · NCT06872125
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
170
Planned (sponsor's estimate)
Start
Jun 4, 2025
Primary completion
Mar 2027
Study completion Oct 2028
Sponsor
- Lead sponsor
- Stoke Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- Mar 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.
Conditions
- Dravet Syndrome
Interventions
zorevunersenDrug
Treatment Period 1: Zorevunersen group will receive study drug by intrathecal (IT) administration on Day 1 (after the 8-week Baseline Period), Day 57 (Week 8), Day 169 (Week 24), and Day 281 (Week 40) at a dose level of 70 mg on Day 1 and Day 57, and 45 mg on Day 169 and Day 281. Treatment Period 2: Group assigned to zorevunersen in Treatment Period 1 will receive 45 mg of zorevunersen on Day 393 (Week 56), Day 477 (Week 68), and Day 589 (Week 84).
Sham ComparatorOther
Treatment Period 1: Sham group will not have drug administered. Sham group will have a procedure intended to mimic the drug administration. Treatment Period 2: Group assigned to sham in Treatment Period 1 will receive 70 mg of zorevunersen on Day 393 (Week 56) and on Day 477 (Week 68), and 45 mg of zorevunersen Day 589 (Week 84).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measurement of Seizure ChangeTime frame: Week 28
Locations
61 sites in 8 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona
Arkansas Children's Hospital
Little Rock, Arkansas
Cedars Sinai Medical Center
Los Angeles, California
Children's Hospital of Orange County
Orange, California
USCF Medical Center
San Francisco, California
Children's Hospital Colorado
Aurora, Colorado
Children's National Medical Center
Washington D.C., District of Columbia
Nemours Children's Health
Jacksonville, Florida
Nicklaus Children's Hospital
Miami, Florida
Advent Health Neuroscience Research Institute
Orlando, Florida
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Massachusetts General Hospital
Boston, Massachusetts
Boston Children's Hospital
Boston, Massachusetts
CS Mott Children's Hospital
Ann Arbor, Michigan
Mayo Clinic
Rochester, Minnesota
NYU Langone Health
New York, New York
Weill Cornell Medicine
New York, New York
University of Rochester Medical Center
Rochester, New York
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Duke University Health System
Durham, North Carolina
Cleveland Clinic
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
Oregon Health & Science University (OHSU)
Portland, Oregon
LeBonheur Children's Hospital
Memphis, Tennessee
Cook Children's Medical Center
Fort Worth, Texas
Texas Children's Hospital
Houston, Texas
University of Utah Primary Children's Hospital
Salt Lake City, Utah
UVA Health
Charlottesville, Virginia
Peking University First Hospital
Beijing, China
The Second Affiliated Hospital of Guangzhou Medical university
Guangzhou, China
Wuhan Children's Hospital
Wuhan, China
Hôpital de la Timone
Marseille, France
Hôpital Necker - Enfants Malades
Paris, France
Hôpital Robert Debré - Paris
Paris, France
Charité - Campus Virchow-Klinikum
Berlin, Germany
Universitaetsklinikum Bonn AoeR
Bonn, Germany
Universitaetsklinikum Frankfurt Goethe-Universitaet
Frankfurt, Germany
Universitaetsklinikum Freiburg
Friedberg, Germany
Universitaetsklinikum Heidelberg
Heidelberg, Germany
Integriertes Sozialpaediatrisches Zentrum
München, Germany
Showing 40 of 61 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.